Online Prescription of Abortion Drugs in Pro-Life States Rose 25% Last Year Amid Ongoing Lack of Regulations
The Guttmacher Institute’s latest report contributes to ongoing pro-life worries about the increased prevalence of abortion drugs nationwide, which undermines state laws and puts women and babies at risk.
U.S. Senate Committee Launches Investigation into Sales of Dangerous Chemical Abortion Drugs
The committee is urging the FDA to crack down on illegal online sales and restore prior safety regulations on the drugs.
University of Oregon in Eugene to Dispense Abortion Pills to Students
Oregon Right to Life has condemned the efforts to get university providers to prescribe the drugs as ‘deeply irresponsible.’
Pro-Life Advocates Increase Pressure on FDA to Conduct Abortion Pill Review: FDA Head Responds
Pro-life leaders increased pressure on the FDA in relation to its review of the abortion pill mifepristone following a report suggesting that FDA Commissioner Dr. Marty Makary told officials to delay the review until after the midterm elections. Makary has denied the allegations.
‘Progressing Apace’: RFK Jr. Says FDA Review of Dangerous Abortion Pill is Underway
Kennedy’s remarks come after new research published by the Ethics and Public Policy Center (EPPC) found a far higher adverse reaction rate associated with mifepristone than previously reported.
Tagged abortion pillmifepristoneRobert F. Kennedy Jr.Trump administration